148 related articles for article (PubMed ID: 30094896)
1. Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
Song B; Lee K; Lee C; Moon KC
Pathol Int; 2018 Sep; 68(9):509-516. PubMed ID: 30094896
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
3. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
[TBL] [Abstract][Full Text] [Related]
4. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive factors in undifferentiated pleomorphic sarcoma: A long-term study from a large tertiary care urban center.
Gonzalez MR; Clunk MJ; Bedi ADS; Werenski JO; Lang JH; Karczewski D; Sodhi A; Lozano-Calderon SA
J Surg Oncol; 2023 Aug; 128(2):322-331. PubMed ID: 37042427
[TBL] [Abstract][Full Text] [Related]
7. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
[TBL] [Abstract][Full Text] [Related]
8. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
9. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
[TBL] [Abstract][Full Text] [Related]
10. Tail of Superficial Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma After Preoperative Radiotherapy.
Imanishi J; Slavin J; Pianta M; Jackett L; Ngan SY; Tanaka T; Charoenlap C; DI Bella C; Choong PF
Anticancer Res; 2016 May; 36(5):2339-44. PubMed ID: 27127141
[TBL] [Abstract][Full Text] [Related]
11. The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
Kamat NV; Million L; Yao DH; Donaldson SS; Mohler DG; van de Rijn M; Avedian RS; Kapp DS; Ganjoo KN
Am J Clin Oncol; 2019 Feb; 42(2):166-171. PubMed ID: 30557163
[TBL] [Abstract][Full Text] [Related]
12. MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name?
Delisca GO; Mesko NW; Alamanda VK; Archer KR; Song Y; Halpern JL; Schwartz HS; Holt GE
J Surg Oncol; 2015 Feb; 111(2):173-7. PubMed ID: 25219789
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
[TBL] [Abstract][Full Text] [Related]
14. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
15. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Lee AY; Agaram NP; Qin LX; Kuk D; Curtin C; Brennan MF; Singer S
Ann Surg Oncol; 2016 Mar; 23(3):818-25. PubMed ID: 26759307
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.
Ozcelik M; Seker M; Eraslan E; Koca S; Yazilitas D; Ercelep O; Ozaslan E; Kaya S; Hacibekiroglu I; Menekse S; Aksoy A; Taskoylu BY; Varol U; Arpaci E; Ciltas A; Oksuzoglu B; Zengin N; Gumus M; Aliustaoglu M
Tumour Biol; 2016 Apr; 37(4):5231-7. PubMed ID: 26553363
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
18. What is an adequate margin for infiltrative soft-tissue sarcomas?
Fujiwara T; Stevenson J; Parry M; Tsuda Y; Tsoi K; Jeys L
Eur J Surg Oncol; 2020 Feb; 46(2):277-281. PubMed ID: 31627932
[TBL] [Abstract][Full Text] [Related]
19. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution.
Sanfilippo R; Miceli R; Grosso F; Fiore M; Puma E; Pennacchioli E; Barisella M; Sangalli C; Mariani L; Casali PG; Gronchi A
Ann Surg Oncol; 2011 Mar; 18(3):720-5. PubMed ID: 20878245
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes.
Fujiwara T; Zhang L; Chandler A; Sung S; Yakoub M; Linkov I; Hameed M; Healey JH
Hum Pathol; 2023 Apr; 134():30-44. PubMed ID: 36565726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
